Literature DB >> 25640523

Usefulness of circulating amino acid profile and Fischer ratio to predict severity of pulmonary hypertension.

Ryoji Yanagisawa1, Masaharu Kataoka2, Takumi Inami1, Yuichi Momose1, Takashi Kawakami3, Makoto Takei3, Mai Kimura3, Sarasa Isobe3, Minoru Yamakado4, Keiichi Fukuda3, Hideaki Yoshino1, Motoaki Sano3, Toru Satoh1.   

Abstract

Plasma amino acid concentrations (aminogram) show distinct patterns under various pathologic conditions. However, the plasma aminogram pattern in patients with pulmonary hypertension (PH) has not been elucidated. We sought to examine whether an aminogram could be predictive of clinical severity in patients with PH. We attained fasting plasma aminograms for 140 patients with PH and then compared the patient plasma amino acid levels with those of age- and gender-matched healthy control subjects. Aminograms revealed that the plasma concentrations of many amino acids were significantly different between patients with PH and healthy control subjects. We focused on the Fischer ratio (branched-chain amino acids/aromatic amino acids) as an integrated parameter. In all enrolled patients, Fischer ratio was negatively correlated with New York Heart Association functional class (ρ = -0.37, p <0.001), plasma B-type natriuretic peptide (ρ = -0.35, p <0.001), and pulmonary vascular resistance (ρ = -0.27, p = 0.002) and positively correlated with venous oxygen saturation (ρ = 0.27, p = 0.002) and 6-minute walk distance (ρ = 0.23, p = 0.016). Time course changes in Fischer ratio and in cardiac output were significantly correlated (ρ = 0.39, p = 0.024). The aminogram is changed in patients with PH, and in these patients, Fischer ratio decreases in proportion to the clinical severity of PH.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640523     DOI: 10.1016/j.amjcard.2014.12.048

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Novel biomarkers for pulmonary arterial hypertension.

Authors:  Anjum Anwar; Gregoire Ruffenach; Aman Mahajan; Mansoureh Eghbali; Soban Umar
Journal:  Respir Res       Date:  2016-07-20

Review 2.  Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary Hypertension.

Authors:  Vanessa Rameh; Antoine Kossaify
Journal:  Biomark Insights       Date:  2016-06-23

3.  A unique gut microbiota signature in pulmonary arterial hypertension: A pilot study.

Authors:  Arun Jose; Senu Apewokin; Walaa E Hussein; Nicholas J Ollberding; Jean M Elwing; David B Haslam
Journal:  Pulm Circ       Date:  2022-02-28       Impact factor: 2.886

4.  The serum amino acid profile in COVID-19.

Authors:  Alptug Atila; Handan Alay; Mehmet Emrah Yaman; Tugrul Cagri Akman; Elif Cadirci; Burak Bayrak; Saffet Celik; Nihal Efe Atila; Aycan Mutlu Yaganoglu; Yucel Kadioglu; Zekai Halıcı; Emine Parlak; Zafer Bayraktutan
Journal:  Amino Acids       Date:  2021-10-04       Impact factor: 3.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.